TMLP yields 2.06% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, TMLP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TMLP + JNJ for your $10,000?
TMLP provides exposure to the MLP universe through a market cap-weighted index of US master limited partnerships (MLPs) and limited liability companies. MLPs are publicly listed partnerships that focus on the transportation, production, processing, or storage of energy commodities. To be included in the index, the company must be 1) in the domiciled and traded in the US, 2) have at least $200 million USD in market cap and 3) maintain an average of $175 million USD in market-cap for a minimum of 20 trading days prior to the rebalance reference date. The fund intends to seek exposure to the underlying index by primarily investing in total return swaps that reference the components of the underlying index. It may, additionally, directly hold the securities of the index constituents up to 25% of its total assets only. A 7.5% capping is also applied to individual positions alongside a 15% limit to securities of an MLP Affiliate family. The index is rebalanced on a quarterly basis.
Full TMLP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.